Most cases of PR are self-limited and require no treatment. Reassurance is offered and topical emollients may diminish the appearance of scale.[11]Contreras-Ruiz J, Peternel S, Jiménez Gutiérrez C, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819167
http://www.ncbi.nlm.nih.gov/pubmed/31684696?tool=bestpractice.com
For patients with pruritus, treatment is symptomatic. However, there is an inadequate evidence base to support the use of the treatments currently used in clinical practice.[11]Contreras-Ruiz J, Peternel S, Jiménez Gutiérrez C, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819167
http://www.ncbi.nlm.nih.gov/pubmed/31684696?tool=bestpractice.com
Mild to moderate symptoms
Oral antihistamines are used to reduce symptoms of pruritus. Nonsedating antihistamines (e.g., loratadine, fexofenadine, cetirizine) can be given in the morning, while sedating antihistamines (e.g., hydroxyzine) are usually given in the evening. In patients with symptoms causing constant itching that interferes with daily activities, low-to-mid-potency topical corticosteroids such as hydrocortisone may also be used, depending on the severity of the rash and symptoms.[11]Contreras-Ruiz J, Peternel S, Jiménez Gutiérrez C, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819167
http://www.ncbi.nlm.nih.gov/pubmed/31684696?tool=bestpractice.com
[22]Villalon-Gomez JM. Pityriasis rosea: diagnosis and treatment. Am Fam Physician. 2018 Jan 1;97(1):38-44.
https://www.aafp.org/afp/2018/0101/p38.html
http://www.ncbi.nlm.nih.gov/pubmed/29365241?tool=bestpractice.com
Severe or refractory symptoms
For patients with more severe symptoms, or those unresponsive to lower-potency therapies, more potent antipruritic agents may be beneficial. These include: doxepin, a tricyclic antidepressant with limited evidence to support its use for the short-term relief of pruritus; and/or higher-potency topical corticosteroids (e.g., triamcinolone).
Narrow-band ultraviolet-B (UVB) may also be used.[22]Villalon-Gomez JM. Pityriasis rosea: diagnosis and treatment. Am Fam Physician. 2018 Jan 1;97(1):38-44.
https://www.aafp.org/afp/2018/0101/p38.html
http://www.ncbi.nlm.nih.gov/pubmed/29365241?tool=bestpractice.com
This requires a significant commitment by the patient to attend all sessions. However, there is no good evidence that UVB results in shortening of duration or improvement of symptoms.[11]Contreras-Ruiz J, Peternel S, Jiménez Gutiérrez C, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819167
http://www.ncbi.nlm.nih.gov/pubmed/31684696?tool=bestpractice.com
Refractory to all other treatments
For select patients resistant to all other therapies, the use of systemic corticosteroids may be considered, although such use remains controversial.[11]Contreras-Ruiz J, Peternel S, Jiménez Gutiérrez C, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819167
http://www.ncbi.nlm.nih.gov/pubmed/31684696?tool=bestpractice.com
[22]Villalon-Gomez JM. Pityriasis rosea: diagnosis and treatment. Am Fam Physician. 2018 Jan 1;97(1):38-44.
https://www.aafp.org/afp/2018/0101/p38.html
http://www.ncbi.nlm.nih.gov/pubmed/29365241?tool=bestpractice.com
[28]Drago F, Rebora A. Treatments for pityriasis rosea. Skin Therapy Lett. 2009 Mar;14(3):6-7.
http://www.skintherapyletter.com/2009/14.3/2.html
http://www.ncbi.nlm.nih.gov/pubmed/19585058?tool=bestpractice.com
[29]Tay YK, Goh CL. One-year review of pityriasis rosea at the National Skin Centre, Singapore. Ann Acad Med Singapore. 1999 Nov;28(6):829-31.
http://www.ncbi.nlm.nih.gov/pubmed/10672397?tool=bestpractice.com
Reserve prednisone for patients in severe discomfort from this condition, and who are refractory to topical corticosteroids and antihistamines. It should be noted that this may help symptoms, but will not shorten the disease course or improve the appearance of the lesions.